ROMAGNOLI, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 439
EU - Europa 421
AS - Asia 103
AF - Africa 4
SA - Sud America 1
Totale 968
Nazione #
US - Stati Uniti d'America 437
RU - Federazione Russa 190
IT - Italia 83
PL - Polonia 60
IE - Irlanda 36
SG - Singapore 36
HK - Hong Kong 26
CN - Cina 21
SE - Svezia 21
CH - Svizzera 17
IN - India 9
JO - Giordania 9
DE - Germania 5
CI - Costa d'Avorio 4
FI - Finlandia 4
CA - Canada 2
ES - Italia 2
FR - Francia 2
VN - Vietnam 2
BR - Brasile 1
NL - Olanda 1
Totale 968
Città #
Santa Clara 124
Warsaw 60
Dublin 36
Chandler 35
Fairfield 30
Singapore 26
Ashburn 25
Cambridge 18
Hong Kong 18
Bern 17
Florence 17
Woodbridge 16
Seattle 15
Wilmington 15
Altamura 12
Lawrence 12
Houston 11
Moscow 9
Mumbai 8
Ann Arbor 7
Beijing 7
Princeton 7
Shanghai 7
Pian di Scò 6
San Diego 6
Buffalo 5
Medford 5
New York 5
Abidjan 4
Boston 4
Bremen 4
Kent 4
Los Angeles 4
Fiesole 3
Helsinki 3
Milan 3
Prato 3
San Jose 3
Yubileyny 3
Boardman 2
Dong Ket 2
Moena 2
Paris 2
Pavia 2
Reston 2
Sesto Fiorentino 2
Seville 2
Siena 2
Villa Minozzo 2
West Jordan 2
Andover 1
Azzano Decimo 1
Bientina 1
Brescia 1
Castelliri 1
Chieri 1
Erice 1
Falls Church 1
Fiumicino 1
Fuzhou 1
Gambassi 1
Hefei 1
Hillsboro 1
Impruneta 1
Landshut 1
Langfang 1
Lappeenranta 1
Livorno 1
Lugo di Vicenza 1
Montreal 1
Nanjing 1
Norwalk 1
Phoenix 1
Pune 1
Redmond 1
Redwood City 1
Rome 1
Romola 1
Saviano 1
Scarperia e San Piero 1
São Paulo 1
Toronto 1
Washington 1
Totale 652
Nome #
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 213
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 124
Long Reads, Short Time: Feasibility of Prenatal Sample Karyotyping by Nanopore Genome Sequencing 111
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features 93
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 78
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 71
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 63
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 61
A blood drop through the pore: nanopore sequencing in hematology 57
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 39
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 32
Resolving complex structural variants via nanopore sequencing 29
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia 13
Totale 984
Categoria #
all - tutte 3.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 11 13 11 15 10 10 5 4
2020/202194 3 8 1 30 7 4 5 5 8 14 7 2
2021/202252 5 1 1 0 1 4 1 11 3 3 5 17
2022/2023200 10 43 17 11 7 27 23 14 16 1 9 22
2023/2024133 9 5 15 7 18 12 3 31 5 10 11 7
2024/2025400 13 62 42 120 163 0 0 0 0 0 0 0
Totale 984